Insurance Pharmaceuticals Self-awareness 
Mad in America
MAY 10, 2025
My journey with this condition led me down a path where I ended up engaging with community efforts to investigate it, to try to spread awareness, and to elucidate aspects that I believe urgently need research so patients can access the correct diagnosis and potential access to treatments. I started freaking out.
Mad in America
AUGUST 9, 2025
I was just a copywriter working in pharmaceutical advertising. The rise of atypical antipsychotics was a business and marketing phenomenon—driven in part by a wave of pharmaceutical mergers in the 1990s. I didn’t set out to shape the field of psychiatry. The agency was in Midtown Manhattan. The client was Johnson & Johnson.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
FEBRUARY 20, 2024
In recent years, there has been a growing awareness surrounding the adverse long-term effects of antidepressants, particularly concerning treatment-emergent sexual dysfunction (TESD). Stephenson and a team of researchers from various academic and pharmaceutical institutions, including the University of Virginia School of Medicine.
Mad in America
DECEMBER 20, 2023
For Part 2, we will be covering reader questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. Was it related to medical insurance or government programs? Moore: The last couple of questions are related to the pharmaceutical industry.
Mad in America
MAY 13, 2025
This simple view has turned complex human experiences into basic disease categories boiling down the rich world of human awareness to a list of disorders that need fixing with chemicals. It puts hope, self-determination, and belonging ahead of just following treatment plans.
Mad in America
JANUARY 6, 2024
One advantage of BetterHelp is that because the service does not bill insurance, there is no need for clinicians to provide a diagnosis and target therapy to fit the “medical necessity” requirements imposed by third-party payers. He didn’t do much to develop evidence that that the thought was irrational, an important part of traditional CBT.
Mad in America
FEBRUARY 1, 2025
Similar trends can be found in many western countries where similar political and business influences, including huge advertising and promotional budgets from pharmaceutical companies, are in place.
Expert insights. Personalized for you.
Let's personalize your content